SpineEx, a medical device company developing spinal implants to improve spinal fusion surgeries, filed on Tuesday with the SEC to raise up to $17 million in an initial public offering.
The Fremont, CA-based company was founded in 2017 and plans to list on the Nasdaq under the symbol SPIX. SpineEx filed confidentially on August 11, 2017. ThinkEquity is the sole bookrunner on the deal. No pricing terms were disclosed.
